Benzinga's Top Initiations
January 31, 2014 at 08:26 AM EST
Analysts at Stifel Nicolaus initiated coverage on shares of Tekmira Pharmaceuticals (NASDAQ: TKMR ) with a “buy” rating. The target price for Tekmira Pharmaceuticals is set to $19. Tekmira's shares closed at $13.00 yesterday. Analysts at Wunderlich initiated coverage on shares of Gas Natural (NYSE: EGAS ) with a
